Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2024

Advanced Osteoporosis, Metabolic Bone Disease & Bone Health Management Update

The Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2024 delivers a comprehensive, evidence-based review of contemporary osteoporosis management, metabolic bone disorders, and emerging therapeutic strategies. This highly regarded educational program brings together leading experts in endocrinology, rheumatology, and bone health to discuss advances in diagnosis, treatment, fracture prevention, and personalized patient care.

Designed for clinicians who manage patients with osteoporosis and complex skeletal disorders, the symposium explores the latest developments in bone biology, osteoanabolic therapies, hormone-related bone health, rare bone diseases, and challenging clinical scenarios encountered in everyday practice.

Product Details

• Course Date: 2024
• Format: 13 Videos + 13 Audios + 13 Subtitle Files (.vtt)
• Size: 13.25 GB
• Access: On-Demand

Program Overview

Osteoporosis and metabolic bone diseases remain major causes of morbidity, disability, and healthcare utilization worldwide. As treatment options continue to expand and clinical guidelines evolve, healthcare professionals must stay current with emerging therapies, safety considerations, and individualized treatment approaches.

The Santa Fe Bone Symposium 2024 provides a practical review of:

• Osteoporosis diagnosis and risk assessment
• Bone density interpretation
• Fracture prevention strategies
• Osteoanabolic therapies
• Antiresorptive medications
• Rare bone disorders
• Hormonal influences on skeletal health
• Orthopedic surgery optimization
• Cardiovascular considerations of osteoporosis treatment
• Bone health in aging populations

The program emphasizes evidence-based clinical decision-making and practical strategies that can be immediately implemented in patient care.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Evaluate emerging therapies for osteoporosis and metabolic bone disease.
• Apply evidence-based treatment strategies for complex osteoporosis patients.
• Manage patients transitioning off denosumab therapy safely and effectively.
• Assess the benefits and risks of osteoporosis medications in patients with cardiovascular disease.
• Understand the role of estrogen, testosterone, and other hormones in skeletal health.
• Optimize bone health before orthopedic procedures and fracture repair.
• Utilize osteoanabolic therapies appropriately in high-risk patients.
• Improve long-term fracture prevention and patient outcomes.

Osteoporosis Management Updates

A major focus of the symposium is the modern management of osteoporosis across diverse patient populations.

Topics include:

• Osteoporosis diagnosis
• Fracture risk assessment
• Bone mineral density evaluation
• Treatment selection strategies
• Monitoring therapeutic response
• Long-term disease management
• Prevention of recurrent fractures

Faculty review current guidelines and practical treatment algorithms for everyday clinical practice.

Emerging Bone Therapeutics

The symposium provides extensive updates on newer osteoporosis medications and treatment strategies.

Topics include:

• Osteoanabolic therapies
• Bone-building agents
• Sequential treatment strategies
• Novel therapeutic targets
• Long-term safety considerations
• Personalized treatment selection

Participants gain insight into integrating emerging therapies into clinical practice.

Denosumab Discontinuation & Treatment Transitions

One of the most challenging areas in osteoporosis management involves treatment transitions.

Sessions review:

• Denosumab discontinuation strategies
• Prevention of rebound bone loss
• Sequential therapy planning
• Fracture risk reduction
• Long-term management considerations

Faculty discuss evidence-based approaches to safely transitioning patients between therapies.

Hormones & Bone Health

Dedicated sessions explore the complex relationship between endocrine function and skeletal health.

Topics include:

• Estrogen deficiency and bone loss
• Testosterone and skeletal maintenance
• Menopause-related osteoporosis
• Hormonal influences on fracture risk
• Endocrine disorders affecting bone metabolism

Participants learn how hormonal factors influence treatment decisions and long-term bone health.

Osteoporosis in Special Populations

The course addresses several challenging patient populations frequently encountered in practice.

Topics include:

• Osteoporosis in the very elderly
• High-fracture-risk patients
• Patients with multiple comorbidities
• Secondary osteoporosis
• Rare metabolic bone disorders
• Complex treatment-resistant cases

Faculty provide practical guidance for individualized patient management.

Cardiovascular Considerations in Osteoporosis Therapy

As newer osteoporosis therapies emerge, understanding cardiovascular safety becomes increasingly important.

Sessions review:

• Cardiovascular effects of osteoporosis medications
• Risk-benefit assessment
• Patient selection considerations
• Safety monitoring strategies
• Evidence from recent clinical studies

Clinicians learn how to balance skeletal benefits with overall patient safety.

Bone Health & Orthopedic Surgery

The symposium highlights strategies to optimize skeletal health before orthopedic interventions.

Topics include:

• Preoperative bone health assessment
• Fracture healing optimization
• Osteoanabolic agents in surgical patients
• Orthopedic outcomes improvement
• Perioperative management strategies

Participants gain practical approaches for improving surgical and long-term outcomes.

Rare Bone Diseases & Complex Cases

Advanced sessions review uncommon skeletal disorders and difficult diagnostic scenarios.

Topics include:

• Rare metabolic bone diseases
• Genetic skeletal disorders
• Diagnostic challenges
• Advanced treatment approaches
• Multidisciplinary care strategies

Faculty share expert insights into managing uncommon but clinically significant bone conditions.

Target Audience

This course is ideal for:

• Endocrinologists
• Rheumatologists
• Primary Care Physicians
• Internal Medicine Physicians
• Geriatricians
• Orthopedic Surgeons
• Nurse Practitioners
• Physician Assistants
• Bone Health Specialists
• Osteoporosis Clinic Providers

   Topics

Topics (13 Lectures):

1. 01 Oral Abstracts Presentations by Endocrinology Fellows

2. 02 Dr. Bobo Tanner, Winner of the Paul D. Miller Award

3. 03 Osteoporosis Treatment in the Very Old

4. 04 Osteoporosis Drugs and Cardiovascular Diseases

5. 05 Case Discussions

6. 06 Management of Patients Discontinuing Denosumab

7. 07 Open Microphone Panel Discussion

8. 08 Estrogen in the Management of Osteoporosis

9. 09 Effects of Testosterone on Bone – Its Role in the Management of Osteoporosis

10. 10 Treat-to-Target for Osteoporosis

11. 11 New and Emerging Therapeutics for Rare Bone Diseases

12. 12 Update on Clinical Aspects and Uses of Osteoanabolic Agents

13. 13 Bone Health Optimization for Orthopedic Surgery